The Clever Leaves plantation was the venue for a government decree that authorizes exports and sales of dry medicinal cannabis to global health entities.
The ruling by the UN’s INCB to slash Colombia’s internal medical-grade cannabis quota reflects the realities of the industry, claims Assocolcann’s Ricardo Arcila.
Legality and social responsibility are corporate pillars for the rapid growth of the Colombian-owned medicinal cannabis company Clever Leaves.
The Canadian parent company of PharmaCielo launched on the Toronto Stock Exchange, Friday, to capitalize their medicinal cannabis growing operations in Colombia.
Five leading physicians spoke with The City Paper about how medical cannabis is helping health professionals deal with the symptoms often associated with terminal illness.
The Colombian Government is expediting licenses for the development and harvest of medicinal marijuana. The National Drug Fund has allocated 40,5 tons of the plant for export to Canada, Peru, Argentina and Paraguay.
Colombia’s Ministry of Health granted a Canadian pharmaceutical company the first license to grow marijuana for medicinal purposes.